US HB3214 | 2011-2012 | 112th Congress
Status
Spectrum: Partisan Bill (Republican 11-0)
Status: Introduced on October 14 2011 - 25% progression, died in committee
Action: 2011-10-18 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on October 14 2011 - 25% progression, died in committee
Action: 2011-10-18 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Food and Drug Administration Mission Reform Act of 2011 - Amends the Federal Food, Drug, and Cosmetic Act to revise the mission of the Food and Drug Administration (FDA) to include establishment of a regulatory system that: (1) advances medical innovation by incorporating modern scientific tools, standards, and approaches; (2) protects the public health and enables patients to access novel products while promoting economic growth, innovation, competitiveness, and job creation among the industries regulated by the FFDCA; (3) is based on the best available science; (4) allows for public participation and an open exchange of ideas; (5) promotes predictability, allows flexibility, and reduces uncertainty; (6) identifies and uses the most innovative and least burdensome tools for achieving regulatory ends; (7) ensures that regulations are accessible, consistent, transparent, written in plain language, and easy to understand; (8) measures, and seeks to improve, the actual results of regulatory requirements; and (9) incorporates a patient-focused benefit-risk framework that accounts for varying degrees of risk tolerance.
Title
Food and Drug Administration Mission Reform Act of 2011
Sponsors
| Rep. Mike J. Rogers [R-MI] | Sen. Marsha Blackburn [R-TN] | Rep. Mary Bono Mack [R-CA] | Rep. John Culberson [R-TX] |
| Rep. Brett Guthrie [R-KY] | Rep. Robert Latta [R-OH] | Rep. Cathy McMorris Rodgers [R-WA] | Rep. Sue Myrick [R-NC] |
| Rep. Erik Paulsen [R-MN] | Rep. Todd Rokita [R-IN] | Rep. John Shimkus [R-IL] |
History
| Date | Chamber | Action |
|---|---|---|
| 2011-10-18 | House | Referred to the Subcommittee on Health. |
| 2011-10-14 | House | Referred to the House Committee on Energy and Commerce. |
Same As/Similar To
SB1972 (Related) 2011-12-08 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Subjects
Administrative law and regulatory procedures
Department of Health and Human Services
Drug safety, medical device, and laboratory regulation
Food and Drug Administration (FDA)
Health technology, devices, supplies
Licensing and registrations
Department of Health and Human Services
Drug safety, medical device, and laboratory regulation
Food and Drug Administration (FDA)
Health technology, devices, supplies
Licensing and registrations
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/112th-congress/house-bill/3214/all-info |
| Text | https://www.congress.gov/112/bills/hr3214/BILLS-112hr3214ih.pdf |
